EMA Authorised: Levetiracetam Hospira (levetiracetam) — Pfizer Europe MA EEIG

View source ↗

Summary

The EMA has granted marketing authorization for Levetiracetam Hospira (levetiracetam) as a generic anti-epileptic drug for epilepsy, with Pfizer Europe MA EEIG …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Levetiracetam Hospira (levetiracetam)

Snippet

Status: Authorised. Therapeutic area: Epilepsy. MAH: Pfizer Europe MA EEIG. Decision date: 12/12/2025